Arkolith/Insider Trading/ABIO/Form 4

Ozeroff Christopher David

S.V.P., General CounselARCA biopharma, Inc. (ABIO) · full profile →Form 4 · filed Nov 23, 2021
Net Buying
Open-Market Buys
$113K
Open-Market Sells
$0
Net Open-Market Flow
$113K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2021Buy(P)50K$2.26$113K51K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-066497) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML